Prognostic factors in patients who survived more than 10 years after undergoing surgery for metastatic brain tumors: report of 5 cases and review of the literature
- PMID: 12453648
- DOI: 10.1016/s0090-3019(02)00753-x
Prognostic factors in patients who survived more than 10 years after undergoing surgery for metastatic brain tumors: report of 5 cases and review of the literature
Abstract
Background: Although the overall prognosis of patients with metastatic brain tumors is dismal, a small number survive longer than 10 years after craniotomy. We report 5 patients who survived for more than 10 years after undergoing treatment for metastatic brain tumor.
Methods: The 5 patients who survived for more than 10 years after undergoing craniotomy were among 56 consecutively treated patients with solitary metastatic brain tumors. We retrospectively examined their clinical course, treatment, and variables associated with their longer survival and compared these 5 patients with other reported cases of metastatic brain tumor.
Results: The histologic tumor types and the sites of origin of the primary tumor varied: two were from lung cancer and one each was from colon cancer, renal cell, and cervical carcinoma of the uterus. Common features among the long-term survivors were: systemic disease was absent, the metastatic tumor was located in the non-eloquent area of the non-dominant hemisphere, they were in good neurologic condition before surgery, there was a long interval between the diagnosis and treatment of the primary lesion and the diagnosis of the brain metastasis, and the patients received postoperative irradiation/chemotherapy.
Conclusion: Aggressive surgical treatment may be justified in young patients with a solitary metastatic brain tumor, as long as they are free of active systemic metastases.
Similar articles
-
Surgical treatment of 70 patients with brain metastases from breast carcinoma.Cancer. 1997 Nov 1;80(9):1746-54. doi: 10.1002/(sici)1097-0142(19971101)80:9<1746::aid-cncr8>3.0.co;2-c. Cancer. 1997. PMID: 9351543
-
Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.J Neurosurg. 2003 Feb;98(2):342-9. doi: 10.3171/jns.2003.98.2.0342. J Neurosurg. 2003. PMID: 12593621
-
Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.J Neurosurg. 2002 Dec;97(6):1276-81. doi: 10.3171/jns.2002.97.6.1276. J Neurosurg. 2002. PMID: 12507123
-
Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases.J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):950-6. doi: 10.1136/jnnp.57.8.950. J Neurol Neurosurg Psychiatry. 1994. PMID: 8057119 Free PMC article. Review.
-
Carcinoma of lung with a solitary cerebral metastasis. Surgical management and review of the literature.Cancer. 1983 Oct 15;52(8):1507-9. doi: 10.1002/1097-0142(19831015)52:8<1507::aid-cncr2820520829>3.0.co;2-z. Cancer. 1983. PMID: 6352002 Review.
Cited by
-
AMD3100 inhibits brain-specific metastasis in lung cancer via suppressing the SDF-1/CXCR4 axis and protecting blood-brain barrier.Am J Transl Res. 2017 Dec 15;9(12):5259-5274. eCollection 2017. Am J Transl Res. 2017. PMID: 29312481 Free PMC article.
-
Factors associated with long-term survival in central nervous system metastases.J Neurooncol. 2018 Oct;140(1):159-164. doi: 10.1007/s11060-018-2946-x. Epub 2018 Jul 12. J Neurooncol. 2018. PMID: 30003395
-
Pericytes Suppress Brain Metastasis from Lung Cancer In Vitro.Cell Mol Neurobiol. 2020 Jan;40(1):113-121. doi: 10.1007/s10571-019-00725-0. Epub 2019 Aug 14. Cell Mol Neurobiol. 2020. PMID: 31414300 Free PMC article.
-
The Evidence That Brain Cancers Could Be Effectively Treated with In-Home Radiofrequency Waves.Cancers (Basel). 2025 Aug 15;17(16):2665. doi: 10.3390/cancers17162665. Cancers (Basel). 2025. PMID: 40867293 Free PMC article.
-
Brain metastases: epidemiology and pathophysiology.J Neurooncol. 2005 Oct;75(1):5-14. doi: 10.1007/s11060-004-8093-6. J Neurooncol. 2005. PMID: 16215811 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical